In today’s fiercely competitive pharmaceutical landscape, companies grapple with the pressing need to amplify sales figures while ensuring optimal performance from their sales teams. The market, constantly influx with new entrants, demands that pharma companies do more with fewer resources to maintain a competitive edge.
Traditional sales approaches struggle to keep pace in this ever-evolving environment. Sales representatives find themselves overwhelmed by mounting workloads and rising organizational expectations. Expanding territories necessitate reps to engage with more healthcare providers in increasingly limited timeframes, all while contending with the rapidly changing needs and preferences of their customer base.
To drive sales, pharma companies must pivot toward personalized approaches for diverse customer segments. Sales reps, however, lack the necessary tools to effectively analyze the vast reservoirs of customer data and insights. This is where artificial intelligence (AI) comes into play, offering transformative solutions to bolster sales representatives’ capabilities, efficiency, and their capacity to deliver personalized experiences.
AI presents a pivotal opportunity for pharmaceutical companies to augment sales team performance, extend outreach, and bolster revenues. It equips sales teams with digital tools that automate routine tasks and furnish actionable insights and guidance on the best actions to take next. With AI support, sales representatives can focus more on tailored engagement with the most promising prospects, thus significantly enhancing their performance. Ultimately, AI’s role is to uplift sales rep effectiveness, efficiency, and foster personalized customer interactions.
Boosting Sales Rep Performance with AI
In today’s data-rich healthcare landscape, companies are turning to artificial intelligence to enhance the performance of their sales representatives. With an abundance of customer and prescription data at their fingertips, AI emerges as a potent tool to enable sales reps to engage with physicians in more impactful ways. Consequently, these companies are delving into the potential of cutting-edge technologies such as machine learning and predictive analytics to empower sales teams and drive improvements in prescription volumes and sales cycle times.
The synergy between AI and sales representatives can be explored through several key facets, each offering a unique vantage point on how AI propels sales success.
A. Leveraging AI for Targeted Sales
Tailored Recommendation/Suggestions by Physician: Pharma AI equips sales reps with the ability to offer tailored discussions to healthcare providers. By analyzing historical data and individual preferences, AI-driven systems can suggest the most relevant topic to discuss with the physician, thereby fostering more meaningful and effective discussions during sales interactions. This has been implemented by many pharma for over a decade using AI now. Pharma not doing this are at a serious disadvantage.
Notably, personalized recommendations have been shown to boost sales by 5-15%, as revealed in a study by McKinsey.
Predicting Physician Needs: With predictive analytics, AI assists sales reps in anticipating HCP needs before they’re explicitly expressed. This foresight enables proactive engagement, positioning the sales representative as a proactive partner in the healthcare provider’s decision-making process.
Precision Doctor Targeting: Numerous elements influence when healthcare professionals might draft the next prescription for a specific patient, along with the pivotal ways these choices can be swayed or prompted. Precision targeting of physicians empowers AI-supported sales teams to gain deeper insights into these factors, enabling more refined and precise targeting and segmentation. This approach offers crucial insights into engaging decision-makers swiftly, reducing the prescription process, enhancing prescriber allegiance, averting brand shifts (as elaborated below), captivating neglected healthcare practitioners, and much more.
HCP Switching Prediction: Cutting-edge artificial intelligence algorithms can now scrutinize the online activities of physicians, including their search behavior during trials and interactions on social media platforms, to generate remarkably precise forecasts regarding their loyalty to specific brands. These algorithms enable the reengagement of physicians contemplating a switch, unveiling the underlying reasons for their inclination, and addressing these concerns effectively. Factors such as consistent top-notch service, the provision of valuable services, respectful treatment, and a profound understanding of their practice significantly contribute to fostering brand loyalty, even in the presence of generics and biosimilars. Conversely, physicians considering a shift from a competitor’s product necessitate prompt engagement. This involves facilitating easy access to research and trial data, embracing a service-centric approach during sales discussions, and harnessing the power of AI-driven omnichannel interactions. These strategies are pivotal in captivating and retaining physicians on the brink of switching, thereby enhancing brand allegiance.
Optimizing Sales Territory Management: AI aids in optimizing sales territories by analyzing geographic and demographic data, This analysis enables the creation of territories that strike a balance between workload and potential sales opportunities.
In practice, AI-optimized territories can lead to a remarkable 20% increase in sales productivity, according to a report by the Harvard Business Review.
B. Improving Sales Efficiency and Productivity
Automation of Administrative Tasks: In a sales rep’s daily routine, administrative tasks often consume a significant amount of time. AI-driven pharmaceutical solutions streamline these tasks, handling functions like appointment scheduling, expense reporting, and order processing. This automation liberates sales reps to allocate more time to customer-facing activities.
A PwC study found that automating these tasks can free up as much as 40% of a sales rep’s time.
Streamlining Data Entry and Reporting: AI’s capacity to interpret and input data directly into CRM systems significantly reduces the time spent on manual data entry. This enhancement enables sales representatives to focus more on engaging with healthcare providers and less on paperwork.
Companies leveraging AI for data entry report a 30% increase in sales productivity, according to data from McKinsey & Company.
C. Enhancing Customer Engagement
Precision omnichannel event sequencing: Next-best action marketing depends on knowing, on a customer-by-customer basis, which sequence of events is most likely to provide the highest level of success, as determined by factors identified by a sales team. Artificial intelligence is able to do this better than most humans, and certainly faster and at a much larger scale. As a result, sales representatives know that Practitioner A responds best to new drugs when first sent a message immediately following the close of a clinical trial, offered an invitation to the trial result’s public announcement, and then sent eDetailing information a few weeks later that they can interact with on their phone, whereas Practitioner B is more likely to prescribe after sitting down for a face-to-face interaction with a representative, followed immediately by a detailed email, and a follow-up call within the next one to two weeks (but whose interest drops off significantly if left alone too long). Practitioners get information when and how they want, while accurate recommendations and intelligent automations free up sales reps to engage in the most useful conversations at the right time and, most importantly, in the right order.
According to a study by Accenture, 91% of consumers are more likely to shop with brands that provide relevant offers and recommendations.
Studies have shown that personalization can increase email open rates by 26% and conversion rates by 760%, as stated by Instapage.
Real-time Data Insights: AI provides real-time data insights during sales meetings, arming sales reps with information on the latest clinical trials, competitor activities, and market trends. This up-to-date information bolsters the sales pitch, making interactions more informed and impactful.
Improved Customer Experience: Artificial Intelligence pharma contributes to an enriched customer experience by ensuring that sales interactions are not only more efficient but also personalized and customer-centric.
A Salesforce survey reported that 59% of patients are more likely to choose a healthcare provider who uses personalized communication and AI-driven services.
D. Training and Development
AI-Powered Sales Training: Sales training is no longer a one-time event; it has evolved into an ongoing, dynamic process. AI plays a pivotal role in modern sales training by delivering adaptive learning experiences tailored to individual needs and performance data.
This personalized training can result in a 50% increase in knowledge retention, according to the Brandon Hall Group.
AI Whisper Coaching: Whisper coaching involves discreetly guiding sales representatives by softly relaying instructions or advice during their interactions with customers. Traditionally, this guidance was provided by a manager or a more experienced team member. However, owing to AI’s prowess in organizing, analyzing, and extracting insights from vast datasets, it excels at offering precise recommendations for optimal next steps, activities, and delivering assets. The most advanced commercial AI tools available to pharmaceutical sales teams today take this a step further by providing these suggestions instantly—essentially elevating whisper coaching to a whole new level. Consider Cyrano, a cloud-based AI service that scrutinizes interactions across multiple channels and furnishes sales reps with clear, step-by-step recommendations to utilize during calls and meetings. These recommendations encompass what actions to take, what to avoid, what aspects to emphasize, and the language to employ—tailored to resonate with the customer’s preferences. It epitomizes the synergy between AI and sales, showcasing the potential of AI-enhanced sales strategies.
Continuous Learning with AI: AI fosters a culture of continuous learning, offering sales reps access to the latest research, market trends, and competitor insights. This dynamic knowledge equips them to adapt to the ever-evolving pharmaceutical landscape effectively.
Case Studies
Real-world examples of pharmaceutical companies integrating AI into their sales strategies showcase transformative shifts in industry dynamics. Across the pharmaceutical landscape, several prominent companies have adopted AI in diverse ways, highlighting the tangible benefits and efficiencies it brings to sales operations.
One such case is Pfizer who integrated AI into its sales force strategy. By leveraging AI-powered predictive analytics, Pfizer enhanced its sales representatives’ capabilities in targeting healthcare providers effectively. This adoption resulted in a significant uptick, a reported 10% increase in conversion rates, positioning Pfizer as a testament to the effectiveness of AI in sales.
Another compelling example is Novartis who utilized AI to optimize its sales territory management. By incorporating AI-driven algorithms and analytics, Novartis strategically restructured its sales territories, yielding a remarkable 20% increase in sales productivity.
Furthermore, Merck & Co showcased the impact of AI in reducing administrative burdens on their sales force. By integrating AI-driven automation tools, Merck achieved a notable 30% reduction in administrative tasks, allowing their sales representatives to focus more on customer engagement and sales-related activities.
These real-world case studies underscore how the adoption of AI in Pharma has led to enhanced efficiency, improved targeting, and increased productivity for sales representatives within these pharmaceutical companies.
Steps to Implement AI for Sales Rep Performance
The infusion of pharma AI into sales strategies is a dynamic journey that demands a structured approach. To leverage the full spectrum of benefits AI offers, pharmaceutical companies need to embark on a well-defined path, marked by crucial steps, ensuring successful implementation and continuous enhancement in sales rep performance.
A. Assessing Your Needs
The first critical step in deploying an AI solution involves a comprehensive assessment of needs and objectives. Pharmaceutical companies must meticulously scrutinize current sales processes, data collection methods, representative workloads, performance metrics, and the envisioned future state.
Questions to consider include:
1. What are the core challenges being faced by your sales reps around the HCPs and their engagement?
2. How much time do representatives allocate to administrative tasks versus HCP engagement?
3. What primary metrics are tracked, and how could additional data sources enrich the insights?
4. Where is performance inconsistency observed across different regions or therapeutic areas?
Defining clear goals for the AI solution is essential, whether it revolves around optimizing representative activity, refining lead qualification and routing, or enhancing strategic territory planning and resource allocation.
Conducting a comprehensive data audit is vital to comprehend the existing information and identify any data gaps that require attention. Potential integrations between Customer Relationship Management (CRM) systems, Electronic Medical Records (EMR) data, clinical trial databases, and other relevant sources might be necessary. Consulting with representatives through surveys and interviews to understand pain points and priorities provides valuable qualitative insights. Benchmarking against industry peers uncovers best practices and common targets.
Statistics reveal that nearly 57% of business leaders believe that assessing AI readiness is critical for successful implementation, as outlined in a report by PricewaterhouseCoopers.
B. Choosing the Right AI Solutions
Once the needs have been thoroughly assessed, companies must meticulously evaluate the available AI solutions to determine the most suitable options. While machine learning and predictive analytics are becoming increasingly prevalent, the ideal solutions depend on an organization’s priorities, budget, and existing data ecosystem.
For example, a small or mid-sized company may benefit most from basic AI-assisted CRM tools that automate routine tasks and suggest the next best actions, costing roughly $50K-$150K annually.
On the other hand, larger pharmaceutical corporations handling extensive complex customer data may necessitate sophisticated deep-learning models, which could cost over $1 million for implementation. However, these models have the potential for significantly higher returns.
Key criteria for selecting a vendor include assessing integration capabilities with existing IT systems, understanding data requirements and the necessity for data cleansing/preparation, evaluating the ease and speed of deployment, examining the transparency of algorithmic decision-making, and verifying a proven track record of enhancing metrics such as sales productivity, customer retention, and market share within the healthcare sector.
Industry research conducted by McKinsey reveals the primary AI applications in pharmaceutical sales, including predictive lead scoring for opportunity qualification (adopted by 55% of companies), automated customer segmentation (51%), and predictive analytics for sales force optimization (47%). Pilot testing options before full deployment are essential to gauge the real-world impact of these solutions.
C. Training Sales Teams
After implementing the appropriate pharma AI solutions, the success of their adoption relies on the effective training of sales representatives. While AI is intended to enhance the work of reps, some may feel uneasy about the perceived threat of AI replacing human judgment and experience.
Training programs need to emphasize that AI serves to analyze available data and isn’t intended to substitute reps’ essential skills in building relationships, medical expertise, and local market knowledge.
Studies demonstrate that reps who use AI as a guide to improve opportunities and enhance customer interactions, rather than as a replacement for their roles, can achieve up to 25% greater quota attainment.
The training process should be hands-on, incorporating real-world use cases to build reps’ confidence in AI’s capacity to direct them toward the most promising leads.
For instance, engaging in role-playing scenarios on how to conduct guided discussions with low-scoring leads identified by predictive analytics. Moreover, it’s crucial to communicate that AI may not always be entirely accurate due to limitations in data or systems, hence reps still need to apply their expertise.
Continual training through online modules, webinars, and personalized coaching sessions can solidify the appropriate use of AI and identify any necessary adjustments. Leading companies also encourage reps’ adoption of AI through compensation plans that reward metrics such as customer retention and new business wins, rather than solely measuring the number of visits or calls made.
D. Monitoring and Evaluation
To ensure that AI solutions deliver the promised value, continuous monitoring and evaluation of key metrics play a crucial role. It’s imperative for companies to establish baseline performance indicators before implementation, such as average sales per representative, close rates, and customer satisfaction scores.
The impact of AI can be assessed by consistently tracking these same Key Performance Indicators (KPIs) over time and comparing them to the established baselines. Advanced analytics can reveal additional valuable data points, such as identifying which doctor specialties or geographic regions benefit the most from AI support. Monitoring dashboards updated on a weekly or monthly basis provide leadership with real-time insights into the progress.
Regular customer and representative surveys offer qualitative feedback on the influence of AI on interactions and workflows.
For instance, questions can revolve around whether representatives perceive AI as enhancing or hindering their ability to serve clients. Formal evaluations conducted every 6-12 months assess longer-term business outcomes, such as potential increases in market share. If the set targets are not being met as anticipated, adjustments might be necessary for algorithms, data integrations, representative training protocols, or compensation incentives.
Industry studies show the top 25% of companies re-evaluating AI solutions at least annually see up to 30% greater ROI than one-time implementers. Ongoing optimization keeps AI aligned with the evolving needs of both reps and customers.
A study by Gartner shows that companies that utilize AI for sales and marketing will boost profitability by 59% by 2025 through more effective monitoring and evaluation processes.
Conclusion
AI is poised to significantly shape the future of sales and customer engagement. As data sources continue to expand and algorithms evolve, AI will play an increasingly strategic role in optimizing representative time and targeting high-value opportunities.
When implemented through a well-structured process encompassing needs assessment, solution selection, training, and ongoing evaluation, AI showcases robust potential to augment sales productivity, enhance customer retention, and ultimately drive corporate revenue and profits.
However, the success of AI relies on maintaining the human touch – keeping reps central to customer relationships while empowering them with intelligent guidance. A balanced, data-driven approach to AI integration preserves the strengths of representatives while elevating overall performance. Overall, the future appears promising for pharmaceutical organizations strategically leveraging advanced technologies like AI to revolutionize their sales methodologies.
Found this article interesting?
At Eularis, we are here to ensure that AI and FutureTech underpins your pharma success in the way you anticipate it can, helping you achieve AI and FutureTech maturation and embedding it within your organisational DNA.
We are the leaders in creating future-proof strategic AI blueprints for pharma and can guide you on your journey to creating real impact and success with AI and FutureTech in your discovery, R&D and throughout the biopharma value chain and help identify the optimal strategic approach that moves the needle. Our process ensures that you avoid bias as much as possible, and get through all the IT security, and legal and regulatory hurdles for implementing strategic AI in pharma that creates organizational impact. We also identify optimal vendors and are vendor-agnostic and platform-agnostic with a focus on ensuring you get the best solution to solve your specific strategic challenges. If you have a challenge and you believe there may be a way to solve it with AI but are not sure how, contact us for a strategic assessment.
See more about what we do in this area here.
For more information, contact Dr Andree Bates abates@eularis.com.